ConductScience.org, home

Paper39867321

Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition.

Sobral PS and 6 others. RSC Adv, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition. Papers, record 39867321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39867321

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition.
PubMed
Journal
RSC Adv
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-01-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sobral PSPatrícia S
2Carvalho TTiago
3Izadi SShiva
4Castilho AAlexandra
5Silva ZZéliahttps://orcid.org/0000-0001-6660-426X
6Videira PAPaula A
7Pereira FFlorbelahttps://orcid.org/0000-0003-4392-4644

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128613862Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1.J Med Chem2017https://conductscience.org/library/papers/28613862PubMed
218075579Reaching for high-hanging fruit in drug discovery at protein-protein interfaces.Nature2007https://conductscience.org/library/papers/18075579PubMed
333938739Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction.J Med Chem2021https://conductscience.org/library/papers/33938739PubMed
433773287If small molecules immunotherapy comes, can the prime be far behind?Eur J Med Chem2021https://conductscience.org/library/papers/33773287PubMed
534103659PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy.Commun Biol2021https://conductscience.org/library/papers/34103659PubMed
616381955DrugBank: a comprehensive resource for in silico drug discovery and exploration.Nucleic Acids Res2006https://conductscience.org/library/papers/16381955PubMed
734055224Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists.ACS Med Chem Lett2021https://conductscience.org/library/papers/34055224PubMed
835696453Computational discovery of small drug-like compounds as potential inhibitors of PD-1/PD-L1 interactions.J Biomol Struct Dyn2023https://conductscience.org/library/papers/35696453PubMed
935585982Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development.Front Immunol2022https://conductscience.org/library/papers/35585982PubMed
1034769226PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action.Int J Mol Sci2021https://conductscience.org/library/papers/34769226PubMed
1134839997Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction.Eur J Med Chem2022https://conductscience.org/library/papers/34839997PubMed
1226400175PubChem Substance and Compound databases.Nucleic Acids Res2016https://conductscience.org/library/papers/26400175PubMed
1334917131Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases.Front Genet2021https://conductscience.org/library/papers/34917131PubMed
1435450381Design, Synthesis, and Evaluation of PD-1/PD-L1 Antagonists Bearing a Benzamide Scaffold.ACS Med Chem Lett2022https://conductscience.org/library/papers/35450381PubMed
1514632445Random forest: a classification and regression tool for compound classification and QSAR modeling.J Chem Inf Comput Sci2003https://conductscience.org/library/papers/14632445PubMed
1634673001Targeting cryptic-orthosteric site of PD-L1 for inhibitor identification using structure-guided approach.Arch Biochem Biophys2021https://conductscience.org/library/papers/34673001PubMed
1734610423Design, synthesis, and structure-activity relationship of PD-1/PD-L1 inhibitors with a benzo[d]isoxazole scaffold.Bioorg Med Chem Lett2021https://conductscience.org/library/papers/34610423PubMed
1830964291Discovery of [1,2,4]Triazolo[4,3- a]pyridines as Potent Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction.J Med Chem2019https://conductscience.org/library/papers/30964291PubMed
1935629327Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy.Life (Basel)2022https://conductscience.org/library/papers/35629327PubMed
2033619272Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1.Nat Commun2021https://conductscience.org/library/papers/33619272PubMed

See all 66 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41939482Recent advances in drug repurposing for cancer immunomodulation emerging strategies, mechanistic insights, and clinical translation.Front Oncol2026https://conductscience.org/library/papers/41939482PubMed
40559656
A Chemoinformatics Investigation of Spectral and Quantum Chemistry Patterns for Discovering New Drug Leads from Natural Products Targeting the PD-1/PD-L1 Immune Checkpoint, with a Particular Focus on Naturally Occurring Marine Products.
Mar Drugs2025https://conductscience.org/library/papers/40559656PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39867321

GET https://conductscience.org/api/papers/v1/39867321/references?page=2